Position in AZN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,113,559,889
-$25,430,642 QoQ
Shares Held
11,146,292
+2.8% QoQ
Ownership
0.719%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#20
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fisher Asset Management, LLC holds $27,351,121,983 across 14 Drug Manufacturers - General names. AZN ranks #7 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,063,516 | $6,073,333,502 | |
| 2 | MRK |
Merck & Co., Inc.
|
38,516,263 | $4,949,339,795 | |
| 3 | JNJ |
Johnson & Johnson
|
13,307,056 | $3,379,593,012 | |
| 4 | PFE |
Pfizer Inc
|
109,067,291 | $2,626,340,367 | |
| 5 | NVS |
Novartis AG
|
15,523,378 | $2,432,823,800 | |
| 6 | ABBV |
AbbVie Inc.
|
9,497,970 | $2,390,069,170 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
11,146,292 | $2,113,559,889 | |
| 8 | GSK |
GSK plc
|
35,722,792 | $1,872,588,756 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,113,559,889 | 11,146,292 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $2,138,990,531 | 10,845,708 | Shares | Defined | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||